FC
EBS icon

Financial Consulate’s Emergent Biosolutions EBS Stock Holding History

Financial Consulate’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$731 Hold
88
– – ﹤0.01% 1166
2025
Q4 		$1.09K Hold
88
– – ﹤0.01% 998
2025
Q3 		$777 Buy
+88
New +$684 ﹤0.01% 907

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Financial Consulate's EBS Position: Q1 2026 in Review

Financial Consulate held its Emergent Biosolutions (EBS) position steady in Q1 2026 at 88 shares worth $731. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

Financial Consulate first reported a position in EBS in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.09K in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Financial Consulate held 88 shares of Emergent Biosolutions worth $731 as of Q1 2026.
  • Financial Consulate left its Emergent Biosolutions share count unchanged in Q1 2026.
  • Emergent Biosolutions made up ﹤0.01% of Financial Consulate's portfolio in Q1 2026, its #1166 holding.
  • Financial Consulate first reported a position in Emergent Biosolutions in Q3 2025 and has held it in 3 quarters since.
  • Financial Consulate's Emergent Biosolutions position peaked at $1.09K in Q4 2025.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Financial Consulate's 13F filing for Q1 2026, filed 21 Apr 2026.